IndraLab

Statements

(-)-epigallocatechin 3-gallate inhibits MAP3K7. 2 / 2

| 2

reach

"We have shown recently that EGCG inhibits TAK1 kinase activity by occupying C174 site with H-bonds that results in reversible, yet stable inhibition of TAK1 kinase activity (Singh et al., 2016)."

28532672

➶

reach

"EGCG alone inhibited 50% of p-TAK1 (Thr 184/187)."

28532672

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

(-)-epigallocatechin 3-gallate inhibits MAP3K7. 2 / 2

INDRA sources:

Databases

Reading